Protein Tyrosine Phosphatase Nonreceptor Type 2 Expression Does Not Correlate with Viral Load or Response to Direct-Acting Antiviral Therapy in Hepatitis C Virus Infections-Infected Patients
Max Sabev(University Hospital Zurich), Marianne R. Spalinger(University of Zurich), Beat Müllhaupt(University Hospital of Zurich), Michael Scharl(Swiss Integrative Center for Human Health), Achim Weber(University Hospital of Zurich), Sena Blümel(University Hospital Zurich), Silvia Lang(University of Zurich), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Claudia Gottier(University of Zurich)
Cited by 2
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease
|Journal of Crohn s and Colitis|2021|477